S. Silver

发表

Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia.

D. Dorr, D. West, P. Yarnold, 2008, JAMA.

Adoption of gene expression profile testing and association with use of chemotherapy among women with breast cancer.

J. Herman, J. Niland, J. Vandergrift, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Breast Cancer

B. Ljung, E. Winer, S. Edge, 2023, M.D. Anderson Solid Tumor Oncology Series.

Medicare coverage for erythropoiesis-stimulating agents: the perfect storm.

S. Silver, 2008, American health & drug benefits.

Erythropoietin-stimulating agents in oncology.

M. Savona, S. Silver, 2008, Cancer journal.

Impending challenges in the hematopoietic stem cell transplantation physician workforce.

H. Heslop, M. Horowitz, C. Anasetti, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Clinical trials: are they a good buy?

C. Bennett, S. Silver, A. Kelahan, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical T rials: A re T hey a G ood B uy?

C. Bennett, Jared R. Adams, S. Silver, 2001 .

University of Michigan Comprehensive Cancer Center opportunities for improvement project.

M. Waldinger, T. Breslin, S. Silver, 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

The Effect of the 2009 USPSTF breast cancer screening recommendations on breast cancer in Michigan: A longitudinal study

T. Braun, T. Breslin, N. Henry, 2018, The breast journal.

Improving breast cancer care through a regional quality collaborative.

T. Breslin, D. Share, J. Pettinga, 2011, Surgery.

Reassessments of ESAs for cancer treatment in the US and Europe.

J. Armitage, I. Macdougall, C. Bennett, 2010, Oncology.

Monoclonal gammopathy‐associated pure red cell aplasia

N. Young, A. Zingone, O. Simakova, 2016, British journal of haematology.

A Review of Safety, Efficacy, and Utilization of Erythropoietin, Darbepoetin, and Peginesatide for Patients with Cancer or Chronic Kidney Disease: A Report from the Southern Network on Adverse Reactions (SONAR)

J. Armitage, I. Macdougall, C. Bennett, 2012, Seminars in Thrombosis & Hemostasis.

Pilot trial on the use of etanercept and methylprednisolone as primary treatment for acute graft-versus-host disease.

T. Braun, M. Becker, G. Yanik, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

American Society of Hematology/ Physician Consortium for Performance Improvement ®

J. Rainey, S. Allen, D. Halévy, 2009 .

T. Braun, V. Ratanatharathorn, J. Uberti, 2007, American journal of hematology.

Phase 1/2 randomized, placebo-control trial of palifermin to prevent graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT).

T. Braun, D. Weisdorf, B. Blazar, 2006, Blood.

Acute Lymphoblastic Leukemia with Eosinophilia

S. Emerson, C. Hanson, S. Silver, 1990, Medicine.

A Phase I/II Randomized, Placebo-Control Trial of Palifermin to Prevent Graft-Versus- Host Disease (GVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Running head: Palifermin to prevent GVHD

T. Braun, D. Weisdorf, B. Blazar, 2006 .

Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody.

M. Becker, J. Ferrara, V. Ratanatharathorn, 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Expansion of Human Bone Marrow Progenitor Cells in a High Cell Density Continuous Perfusion System

Bernhard O. Palsson, Se-Hwan Paek, B. Palsson, 1993, Bio/Technology.

Anti-CD20 Chimeric Monoclonal Antibody Treatment of Refractory Immune-Mediated Thrombocytopenia in a Patient with Chronic Graft-versus-Host Disease

G. Yanik, J. Ferrara, V. Ratanatharathorn, 2000, Annals of Internal Medicine.

Lowered-intensity preparative regimen for allogeneic stem cell transplantation delays acute graft-versus-host disease but does not improve outcome for advanced hematologic malignancy.

T. Braun, G. Yanik, R. Hutchinson, 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

14 A phase I/II study of recombinant human keratinocyte growth factor (KGF) in patients with high risk hematologic malignancies undergoing mismatched related or unrelated donor transplant

T. Braun, M. Becker, G. Yanik, 2003 .

Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria.

H. Bonkovsky, P. Stein, M. Sweetser, 2020, The New England journal of medicine.

The Graying of Clinical Transplantation

Treasurer, H. Heslop, R. Soiffer, 2006 .

Cutaneous and laryngopharyngeal papules of xanthoma disseminatum successfully treated with 2-chlorodeoxyadenosine

D. Fullen, N. Hogikyan, T. Do, 2018, JAAD case reports.

Time to adjuvant chemotherapy for breast cancer in National Comprehensive Cancer Network institutions.

Yu-Ning Wong, Joyce C Niland, Jane C Weeks, 2013, Journal of the National Cancer Institute.

Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease.

J. Armitage, J. Vose, J. Klein, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

New Guidelines Help Health Professionals Recognize and Manage Late Complications

Treasurer, H. Heslop, R. Soiffer, 2006 .

Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.

L. Dawson, M. Schipper, A. Eisbruch, 2004, International journal of radiation oncology, biology, physics.

Autoimmune Diseases : When Homeland Security Fails

Treasurer, J. Dipersio, R. Truitt, 2004 .

Lower intensity of preparative regimen for allogeneic stem cell transplantation from related donor in patients with advanced hematologic malignancy is associated with poor outcome

G. Yanik, R. Hutchinson, J. Ferrara, 2000 .

NCCN Practice Guidelines for Breast Cancer.

E. Winer, S. Edge, W. Gradishar, 2000, Oncology.

The devil's in the dosing: severe drug-induced liver injury in a hydroxychloroquine-naive patient with subacute cutaneous lupus erythematosus and porphyria cutanea tarda

D. Roofeh, B. Sunkara, S. Silver, 2018, Lupus.

Update: NCCN practice guidelines for the treatment of breast cancer. National Comprehensive Cancer Network.

E. Winer, S. Edge, W. Gradishar, 1999, Oncology.

D. Blayney, S. Silver, 2022, JAMA oncology.

Associations between use of the 21‐gene recurrence score assay and chemotherapy regimen selection in a statewide registry

T. Braun, J. Griggs, T. Breslin, 2017, Cancer.

The NCCN. Invasive breast cancer: Clinical practice guidelines in oncology™

Lawrence B. Marks, Robert W. Carlson, Daniel F. Hayes, 2007 .

GS-14-ENVISION, a phase 3 study to evaluate efficacy and safety of givosiran, an investigational RNAi therapeutic targeting aminolevulinic acid synthase 1, in acute hepatic porphyria patients

H. Bonkovsky, P. Stein, L. Gouya, 2019, Journal of Hepatology.

Clinical presentation of breast cancer: Age, stage, and treatment modalities in a contemporary cohort of Michigan women.

A. Davis, D. Share, J. Kreinbrink, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Invasive breast cancer.

B. Ljung, E. Winer, S. Edge, 2007, Journal of the National Comprehensive Cancer Network : JNCCN.

Roundtable discussion: Incorporating bone marrow transplantation into NCCN guidelines.

M. Tallman, P. Beatty, W. Vaughan, 1998, Oncology.

Variation in the use of advanced imaging at the time of breast cancer diagnosis in a statewide registry

T. Braun, J. Griggs, T. Breslin, 2017, Cancer.

Cancer care for the whole patient-a new institute of medicine report.

S. Silver, 2008, Journal of oncology practice.

NCCN: The Future is Bright.

S. Silver, 2015, The Journal of the National Comprehensive Cancer Network.

Prognostic significance of Philadelphia chromosome-positive cells detected by the polymerase chain reaction after allogeneic bone marrow transplant for chronic myelogenous leukemia.

D. Ginsburg, J. Antin, M. Roth, 1992, Blood.

A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation.

J. L. Goodman, W. Powderly, T. Shea, 1992, The New England journal of medicine.

996 Disease Characteristics of Acute Hepatic Porphyria Patients: ENVISION, a Phase 3 Global, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

H. Bonkovsky, P. Stein, L. Gouya, 2019, American Journal of Gastroenterology.

Nephrotic syndrome associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

T. Braun, V. Ratanatharathorn, P. Reddy, 2006, Bone Marrow Transplantation.

Breast cancer. Clinical practice guidelines in oncology.

Krystyna Kiel, Mohammad Jahanzeb, Ingrid A Mayer, 2009, Journal of the National Comprehensive Cancer Network : JNCCN.

Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody.

M. Becker, J. Ferrara, V. Ratanatharathorn, 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Adapted Application of NCCN Clinical Practice Guidelines in Oncology in the Middle East and North Africa Region

M. Dwyer, Rashmi Kumar, H. Burstein, 2010 .

Improving breast cancer care through a regional quality collaborative.

T. Breslin, D. Share, J. Pettinga, 2011, Surgery.

T. Braun, V. Ratanatharathorn, J. Uberti, 2007, American journal of hematology/oncology.

In vitro expansion of hematopoietic cells for clinical application.

M. Clarke, G. van Zant, S. Emerson, 1995, Cancer treatment and research.